Pulse AI

Cancer patients often face risks post-discharge due to limited monitoring and guidance, leading to complications and higher readmission rates. Our business addresses this gap with an AI-powered virtual ward that replicates the role of a nurse, providing continuous home monitoring, predicting and preventing cancer complications.

The platform integrates real-time physiological monitoring, facial scans, and predictive analytics, offering hospitals actionable insights and patients compassionate care. Data security is a priority, with robust encryption protocols and strict compliance with GDPR to protect patient privacy.

Our solution is uniquely positioned to stand out from other telehealth services due to its focus on cancer care, proprietary algorithms, and seamless integration with hospital workflows. Supported by two successful clinical trials at the University of Leicester and the NHS Accelerator programme, feedback from healthcare professionals highlights its potential to improve patient outcomes and hospital efficiency.

As LLM-based diagnostic technologies evolve, our widely adopted platform will scale to include advanced diagnostic capabilities. With a roadmap that includes additional clinical trials, regulatory approvals, and strategic partnerships, we aim to achieve our long-term vision of becoming a comprehensive digital doctor, transforming cancer care for hospitals and patients worldwide.